<p>INH: isoniazid; DST: drug susceptibility testing; MDR: multidrug-resistant; XDR: extensively drug-resistant</p><p>Specific inhA promoter mutations found in each drug-resistance category.</p
<p>Each line represents the number of cases in each INH resistance mutation group over time. The pro...
Background Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are o...
An examination of the pattern of lipid biosynthetic responses to isoniazid (INH) treatment of Mycoba...
<p>Acquisition of <i>katG</i> S315 mutations precedes all other resistance mutations, including rifa...
SETTING: The single base change at the 94th codon of inhA has been referred to as the event that c...
Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are often few re...
A mutations in drug-resistant TB patients has not been examined.A promoter. We stratified these resu...
Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of...
<div><p>Background</p><p>Isoniazid (INH) is a highly effective antibiotic central for the treatment ...
<p>All strain were resistant to rifampicin (RIF, 1 μg/ml), isoniazid (INH, 1 μg/ml) and pyrazinamide...
Abstract Whole-genome sequencing was used to analyze the profiles of isoniazid (INH) resistance-rela...
Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of...
Background: High-dose isoniazid is recommended in the 9–12 months short-course regimen for multidrug...
Resistance in Mycobacterium tuberculosis to isoniazid (INH) is caused by mutations in the catalase-p...
Background: Specific isoniazid (INH) resistance conferring mutations have been shown to impact the l...
<p>Each line represents the number of cases in each INH resistance mutation group over time. The pro...
Background Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are o...
An examination of the pattern of lipid biosynthetic responses to isoniazid (INH) treatment of Mycoba...
<p>Acquisition of <i>katG</i> S315 mutations precedes all other resistance mutations, including rifa...
SETTING: The single base change at the 94th codon of inhA has been referred to as the event that c...
Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are often few re...
A mutations in drug-resistant TB patients has not been examined.A promoter. We stratified these resu...
Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of...
<div><p>Background</p><p>Isoniazid (INH) is a highly effective antibiotic central for the treatment ...
<p>All strain were resistant to rifampicin (RIF, 1 μg/ml), isoniazid (INH, 1 μg/ml) and pyrazinamide...
Abstract Whole-genome sequencing was used to analyze the profiles of isoniazid (INH) resistance-rela...
Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of...
Background: High-dose isoniazid is recommended in the 9–12 months short-course regimen for multidrug...
Resistance in Mycobacterium tuberculosis to isoniazid (INH) is caused by mutations in the catalase-p...
Background: Specific isoniazid (INH) resistance conferring mutations have been shown to impact the l...
<p>Each line represents the number of cases in each INH resistance mutation group over time. The pro...
Background Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are o...
An examination of the pattern of lipid biosynthetic responses to isoniazid (INH) treatment of Mycoba...
DOI
Add to ORKG